arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

download Export Data

Minerva Neurosciences, Inc.

NERV

$4.25 ▼ -0.17 (-3.96%) at close

14 Visible periods

25 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Good

Bullish

auto_awesome

Analytical Summary

Minerva Neurosciences, Inc. shows strong fundamentals with top-quartile Return on Common Equity (%). The company's metrics support a bullish outlook for growth-oriented investors.

Market Cap $36.0M

Dividend Yield —

Revenue Growth —

Op. Margin None

ROIC 8.5% ↘

FCF / Share $-1.60 ↗

Trailing P/E —

Price / Book —

FCF Yield —

Debt / Equity —

info Valuation on last close. End-of-day price, Aug 7, 2026.

14-Year Financial Trajectory

Annual

Metric Value Trend Year over Year Percentile

Revenue Total top-line sales

$0.00

— —

Net Income Profit after all expenses

$-293.42M

↓ -20492.7% —

FCF / Share Free cash flow per share

$-1.60

↑ +38.2% —

trending_up

Bullish Indicators

Return on Common Equity (%)Return on Common Equity (%) is in the top quartile

warning

Bearish Risks

No bearish risks detected.

Health Breakdown

Returns ↑

100

Cash Quality ↓

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗
EPS Growth YoY (%)	N/M	N/M	23.3% Good Good Year-over-year change in earnings per share Optimal: > 10%	-413.7% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	N/M	N/M	—	—	—	—	—	—	—	—
Net Income Growth YoY (%)	N/M	N/M	6.6% Fair Fair Year-over-year change in net income	35.7% Excellent Excellent Year-over-year change in net income	N/M	N/M	-43.9% Weak ↓ Weak Declining Year-over-year change in net income	-59.2% Weak ↓ Weak Declining Year-over-year change in net income	-1.5% Weak ↑ Weak Improving Year-over-year change in net income	-14.6% Weak ↑ Weak Improving Year-over-year change in net income	52.4% Excellent Excellent Year-over-year change in net income	-1644.4% Weak Weak Year-over-year change in net income	—	—
FCF Growth YoY (%)	38.2% Excellent ↑ Excellent Improving Year-over-year change in free cash flow	-13.7% Weak ↑ Weak Improving Year-over-year change in free cash flow	50.8% Excellent ↑ Excellent Improving Year-over-year change in free cash flow	-701.9% Weak ↓ Weak Declining Year-over-year change in free cash flow	30.5% Excellent Excellent Year-over-year change in free cash flow	25.6% Excellent Excellent Year-over-year change in free cash flow	—	—	—	—	—	—	—	—

💰 Are margins durable? 5 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗
Operating Margin (%) (%)	—	—	—	—	—	4.5% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-70%)	—	—	—	—	—	—	—	—
Effective Tax Rate (%) (%)	—	—	—	—	3.5% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	—	3.0% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	22.9% Fair Fair Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	—	—	—	—
Profit Margin (%) (%)	—	—	—	—	—	4.7% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-61%)	—	—	—	—	—	—	—	—
FCF Margin (%) (%)	—	—	—	—	—	-82.1% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—	—	—	—	—	—	—	—
FCF / Net Income (x)	0.05x Weak ↑ Weak Improving Free cash flow relative to reported net income Optimal: > 1x	-13.59x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.49x Weak ↑ Weak Improving Free cash flow relative to reported net income Optimal: > 1x	0.77x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.49x Weak ↑ Weak Improving Free cash flow relative to reported net income Optimal: > 1x	-17.43x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.60x Weak ↑ Weak Improving Free cash flow relative to reported net income Optimal: > 1x	0.84x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	-0.10x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—	—	—	—	—

🎯 Is capital allocation efficient? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗
Return on Invested Capital (%)	8.5% Fair ↓ Fair Declining Return earned on debt + equity capital invested Optimal: > 10%	67.2% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	64.2% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	99.5% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	-549.0% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	2.8% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-264.8% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-57.3% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-24.1% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-28.5% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-37.3% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-84.2% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	-12.4% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	—
Return on Capital (%) (%)	-15.4% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-58.8% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-40.6% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-45.8% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-58.8% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	3.2% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-97.9% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-37.2% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-22.4% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-22.7% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-31.6% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-80.2% Weak Weak Operating profit relative to total assets Optimal: > 10%	-10.9% Weak Weak Operating profit relative to total assets Optimal: > 10%	—
Return on Common Equity (%) (%)	208.5% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+1290%)	-5.6% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-137%)	105.4% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+603%)	160.3% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+969%)	—	3.7% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-75%)	-259.8% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1832%)	-55.6% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-471%)	-24.0% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-260%)	-29.3% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-295%)	-49.0% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-426%)	-110.5% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-837%)	-16.2% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-208%)	—

⚖️ Is the balance sheet risky? 2 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗
Interest Coverage (x)	—	—	—	—	—	—	—	-556.74x Weak Weak Operating income divided by interest expense Optimal: > 5x	-94.27x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	—	-26.77x Weak Weak Operating income divided by interest expense Optimal: > 5x	-54.69x Weak Weak Operating income divided by interest expense Optimal: > 5x	—
Net Debt (USD)	$-82.30M	$-21.36M	$-40.91M	$-36.09M	$-60.76M	$-25.36M	$-21.41M	$-50.23M	$-26.05M	$-82.98M	$-14.28M	$-18.55M	$-1.82M	$-200.31K

📊 What does each share earn? 6 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗
Revenue per Share (USD)	—	$0.00	$0.00	$0.00	$0.00	$1.01	—	—	—	—	—	—	—	—
Basic EPS, GAAP (USD)	$-34.67	$0.19	$-4.61	$-6.01	$-1.17	$0.05	$-1.85	—	—	—	—	—	—	—
Free Cash Flow per Share (USD)	$-1.60	$-2.58	$-2.27	$-4.62	$-0.58	$-0.83	$-1.11	—	—	—	—	—	—	—
Book Value per Share (USD)	$-3.25	$-3.67	$-4.07	$-3.75	$0.19	$1.23	$0.71	$2.32	$3.40	$3.03	$2.24	$2.79	$3.30	—
Tangible Book Value per Share (USD)	$-3.60	$-5.80	$-6.20	$-6.53	$-0.16	$0.53	$-0.06	$1.06	$2.13	$1.62	$0.25	$0.13	$-1.10	—
Basic Weighted Avg Shares (shares)	8.46M	7.57M	6.51M	5.34M	42.72M	40.82M	39.01M	—	—	—	—	—	—	—

🏦 How resilient is the balance sheet? 2 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗
Working Capital (USD)	$80.81M	$19.43M	$38.66M	$38.78M	$59.38M	$24.28M	$40.51M	$86.41M	$122.70M	$74.18M	$28.16M	$15.83M	$412.59K	—
Total Equity (USD)	$-140.75M	$-25.69M	$-28.46M	$-20.02M	$7.98M	$52.66M	$27.78M	$90.26M	$131.60M	$105.98M	$55.32M	$51.50M	$20.18M	$19.02K

📋 What is driving earnings? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗	FY 2016 Dec 31, 2016 10-K ↗	FY 2015 Dec 31, 2015 10-K ↗	FY 2014 Dec 31, 2014 10-K ↗	FY 2013 Dec 31, 2013 10-K ↗	FY 2012 Dec 31, 2012 10-K ↗
Sales/Revenue/Turnover (USD)	—	$0.00	$0.00	$0.00	$0.00	$41.18M	—	$0.00	—	—	—	—	—	—
Depreciation Expense (USD)	—	—	—	—	—	$16.01K	$17.47K	$17.47K	$11.09K	$16.53K	$17.28K	$33.87K	—	—
Net Income, GAAP (USD)	$-293.42M	$1.44M	$-30.01M	$-32.11M	$-49.91M	$1.94M	$-72.18M	$-50.17M	$-31.52M	$-31.05M	$-27.08M	$-56.90M	$-3.26M	—
Operating Cash Flow (USD)	$-13.51M	$-19.55M	$-14.78M	$-24.65M	$-24.60M	$-33.82M	$-43.43M	$-41.94M	$3.09M	—	—	—	—	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 14 years · 54 quarters

Minerva Neurosciences, Inc.

Analytical Summary

14-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare NERV with peers